Stocks in play: HLS Therapeutics Inc.
Announces that it has entered into a Product Listing Agreement with the province of Alberta, for the listing and public reimbursement of Vascepa (icosapent ethyl). The PLA with Alberta Health is effective August 1. HLS Therapeutics Inc. shares T.HLS are trading unchanged at $3.35.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.